Answers are grounded in this paper and cite their sources.
There is an urgent need for safe, efficacious, affordable, and field-adapted drugs for the treatment of cutaneous leishmaniasis, which newly affects around 1.5 million people worldwide annually. Chitosan, a biodegradable cationic polysaccharide, has previously been reported to have antimicrobial, antileishmanial, and immunostimulatory activities.
No takes yet. Share an insight, caveat, or question.
Riezk et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: